These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 23771326

  • 41. Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience.
    Marin F, Fezzi S, Gambaro A, Ederle F, Castaldi G, Widmann M, Gangemi C, Ferrero V, Pesarini G, Pighi M, Ribichini FL.
    J Nephrol; 2021 Oct; 34(5):1445-1455. PubMed ID: 33481223
    [Abstract] [Full Text] [Related]

  • 42. Vascular and renal hemodynamic changes after renal denervation.
    Ott C, Janka R, Schmid A, Titze S, Ditting T, Sobotka PA, Veelken R, Uder M, Schmieder RE.
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1195-201. PubMed ID: 23559677
    [Abstract] [Full Text] [Related]

  • 43. Safety and efficacy of endovascular ultrasound renal denervation in resistant hypertension: 12-month results from the ACHIEVE study.
    Daemen J, Mahfoud F, Kuck KH, Andersson B, Böhm M, Graf T, Sievert H, Kahlert P, Iyer M, Zeller T.
    J Hypertens; 2019 Sep; 37(9):1906-1912. PubMed ID: 31045964
    [Abstract] [Full Text] [Related]

  • 44. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension.
    Desch S, Okon T, Heinemann D, Kulle K, Röhnert K, Sonnabend M, Petzold M, Müller U, Schuler G, Eitel I, Thiele H, Lurz P.
    Hypertension; 2015 Jun; 65(6):1202-8. PubMed ID: 25824248
    [Abstract] [Full Text] [Related]

  • 45. Renal denervation in patients with resistant hypertension: six-month results.
    Dores H, de Sousa Almeida M, de Araújo Gonçalves P, Branco P, Gaspar A, Sousa H, Canha Gomes A, Andrade MJ, Carvalho MS, Campante Teles R, Raposo L, Mesquita Gabriel H, Pereira Machado F, Mendes M.
    Rev Port Cardiol; 2014 Apr; 33(4):197-204. PubMed ID: 24472425
    [Abstract] [Full Text] [Related]

  • 46. Does the presence of accessory renal arteries affect the efficacy of renal denervation?
    Id D, Kaltenbach B, Bertog SC, Hornung M, Hofmann I, Vaskelyte L, Sievert H.
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1085-91. PubMed ID: 24156968
    [Abstract] [Full Text] [Related]

  • 47. Impact of local vascular lesions assessed with optical coherence tomography and ablation points on blood pressure reduction after renal denervation.
    Ghadri JR, Gaehwiler R, Jaguszewski M, Sudano I, Osipova J, Schoenenberger-Berzins R, Erne P, Lüscher TF, Templin C.
    Swiss Med Wkly; 2015 Oct; 145():w14102. PubMed ID: 25658048
    [Abstract] [Full Text] [Related]

  • 48. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.
    Schlaich MP, Bart B, Hering D, Walton A, Marusic P, Mahfoud F, Böhm M, Lambert EA, Krum H, Sobotka PA, Schmieder RE, Ika-Sari C, Eikelis N, Straznicky N, Lambert GW, Esler MD.
    Int J Cardiol; 2013 Oct 03; 168(3):2214-20. PubMed ID: 23453868
    [Abstract] [Full Text] [Related]

  • 49. Catheter-based renal denervation for treatment of resistant hypertension.
    Vase H, Mathiassen ON, Kaltoft A, Pedersen EB, Christensen KL, Buus NH, Lederballe O, Lassen JF, Bøtker HE, Thuesen L.
    Dan Med J; 2012 Jun 03; 59(6):A4439. PubMed ID: 22677237
    [Abstract] [Full Text] [Related]

  • 50. The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence.
    Ott C, Mahfoud F, Schmid A, Ewen S, Toennes SW, Meyer MR, Helfer AG, Maurer HH, Ditting T, Veelken R, Zivanovic I, Uder M, Böhm M, Schmieder RE.
    J Hypertens; 2016 Dec 03; 34(12):2475-2479. PubMed ID: 27607458
    [Abstract] [Full Text] [Related]

  • 51. Anatomical and procedural determinants of ambulatory blood pressure lowering following catheter-based renal denervation using radiofrequency.
    Lauder L, Ewen S, Tzafriri AR, Edelman ER, Cremers B, Kulenthiran S, Ukena C, Linz D, Kindermann I, Tsioufis C, Scheller B, Böhm M, Mahfoud F.
    Cardiovasc Revasc Med; 2018 Dec 03; 19(7 Pt B):845-851. PubMed ID: 29555535
    [Abstract] [Full Text] [Related]

  • 52. Blood pressure variability after catheter-based renal sympathetic denervation in patients with resistant hypertension.
    Ewen S, Dörr O, Ukena C, Linz D, Cremers B, Laufs U, Hamm C, Nef H, Bauer A, Mancia G, Böhm M, Mahfoud F.
    J Hypertens; 2015 Dec 03; 33(12):2512-8. PubMed ID: 26485461
    [Abstract] [Full Text] [Related]

  • 53. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
    Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A.
    Hypertension; 2014 May 03; 63(5):991-9. PubMed ID: 24591332
    [Abstract] [Full Text] [Related]

  • 54. Improvement of albuminuria after renal denervation.
    Ott C, Mahfoud F, Schmid A, Ditting T, Veelken R, Ewen S, Ukena C, Uder M, Böhm M, Schmieder RE.
    Int J Cardiol; 2014 May 01; 173(2):311-5. PubMed ID: 24681017
    [Abstract] [Full Text] [Related]

  • 55. Ultra-long-term efficacy and safety of catheter-based renal denervation in resistant hypertension: 10-year follow-up outcomes.
    Al Ghorani H, Kulenthiran S, Lauder L, Recktenwald MJM, Dederer J, Kunz M, Götzinger F, Ewen S, Ukena C, Böhm M, Mahfoud F.
    Clin Res Cardiol; 2024 Oct 01; 113(10):1384-1392. PubMed ID: 38451261
    [Abstract] [Full Text] [Related]

  • 56. Accessory renal arteries: Prevalence in resistant hypertension and an important role in nonresponse to radiofrequency renal denervation.
    VonAchen P, Hamann J, Houghland T, Lesser JR, Wang Y, Caye D, Rosenthal K, Garberich RF, Daniels M, Schwartz RS.
    Cardiovasc Revasc Med; 2016 Oct 01; 17(7):470-473. PubMed ID: 27493150
    [Abstract] [Full Text] [Related]

  • 57. Effects of renal sympathetic denervation on blood pressure and glycaemic control in patients with true resistant hypertension: results of Polish Renal Denervation Registry (RDN-POL Registry).
    Kądziela J, Prejbisz A, Kostka-Jeziorny K, Dudek D, Narkiewicz K, Sadowski J, Lekston A, Gziut A, Więcek A, Buszman P, Kleinrok A, Kochman J, Czarnecka D, Januszewicz A, Witkowski A.
    Kardiol Pol; 2016 Oct 01; 74(9):961-8. PubMed ID: 27160171
    [Abstract] [Full Text] [Related]

  • 58. Efficacy and Safety of Radiofrequency-Based Renal Denervation on Resistant Hypertensive Patients: A Systematic Review and Meta-analysis.
    Sobreira LER, Bezerra FB, Sano VKT, de Oliveira Macena Lôbo A, Cardoso JHCO, Kelly FA, de Moraes FCA, Consolim-Colombo FM.
    High Blood Press Cardiovasc Prev; 2024 Jul 01; 31(4):329-340. PubMed ID: 38890242
    [Abstract] [Full Text] [Related]

  • 59. Effects of renal sympathetic denervation on cardiac sympathetic activity and function in patients with therapy resistant hypertension.
    van Brussel PM, Eeftinck Schattenkerk DW, Dobrowolski LC, de Winter RJ, Reekers JA, Verberne HJ, Vogt L, van den Born BJ.
    Int J Cardiol; 2016 Jan 01; 202():609-14. PubMed ID: 26447672
    [Abstract] [Full Text] [Related]

  • 60. Effect of catheter-based renal sympathetic denervation on 24-h ambulatory blood pressure in patients with resistant hypertension.
    Völz S, Andersson B, Manhem K, Haraldsson I, Rundqvist B.
    Blood Press; 2014 Aug 01; 23(4):228-32. PubMed ID: 24432803
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.